secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indivior Pharmaceuticals, Inc. (INDV)
CIK:        0001625297
Form:       8-K
Filed at:   2026-08-03T12:32:42+00:00
Accession:  0001193125-26-329618
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indivior and Supernus announce merger of equals to create diversified CNS leader
--------------------------------------------------------------------------------

- Merger of equals under Agreement and Plan of Merger dated August 1, 2026.
- Joint investor presentation and conference call held on August 3, 2026.
- Transaction includes a special dividend and additional indebtedness; terms not disclosed.
- Closing subject to stockholder and regulatory approvals; S-4 registration statement to be filed.
- Combined company expected to have significant scale in CNS biopharmaceuticals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625297/000119312526329618/0001193125-26-329618-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625297/000119312526329618/d166865d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-329618

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer